Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

Details for Australian Patent Application No. 2005233560 (hide)

Owner Theravance, Inc.

Inventors Marquess, Daniel; Genov, Daniel; Choi, Seok-Ki; Fatheree, Paul R.; Goldblum, Adam A.; Turner, Derek S.; Long, Daniel D.

Agent Davies Collison Cave

Pub. Number AU-B-2005233560

PCT Pub. Number WO2005/100350

Priority 60/560,076 07.04.04 US

Filing date 6 April 2005

Wipo publication date 27 October 2005

Acceptance publication date 5 April 2012

International Classifications

C07D 451/04 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/100350 Priority application(s): WO2005/100350

5 April 2012 Application Accepted

  Published as AU-B-2005233560

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005233564-Orphan receptor tyrosine kinase as a target in breast cancer

2005233559-Canine cold-and menthol-sensitive receptor 1